Piperacillin: Clinical Trials

8 trials of Piperacillin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 unknown. 8 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 38Completed 6, Unknown 2
Phase 21Unknown 1

Follow Piperacillin: new trials by email Literature Review of Piperacillin trials Research Report on Piperacillin

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit
Piperacillin/tazobactam or temocillin, Meropenem - Sepsis, Septic Shock
Phase 3UnknownAssistance Publique - Hôpitaux de Paris6002023-03-112023-04-18
Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)
Imipenem, Relebactam, Cilastatin - Bacterial Pneumonia
Phase 3CompletedMerck Sharp & Dohme LLC5372015-11-242020-04-16
Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
Meropenem-Vaborbactam, Piperacillin-Tazobactam, Levofloxacin - Urinary Tract Infection Complicated, Acute Pyelonephritis
Phase 3CompletedMelinta Therapeutics, Inc.5502014-11-202018-06-11
Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)
Ertapenem sodium, Piperacillin/tazobactam sodium, Piperacillin/tazobactam-matching placebo - Infection; Diabetic Foot
Phase 3CompletedMerck Sharp & Dohme LLC5652011-09-022018-08-27
Antibiotic Treatment in Ventilator Associated Tracheobronchitis (VAT)
Piperacillin/Tazobactam for 7 days - Tracheobronchitis
Phase 2 / Phase 3UnknownAssaf-Harofeh Medical Center1002009-09-012009-12-09
Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection
Moxifloxacin (Avelox, BAY12-8039), Piperacillin/Tazobactam & Amoxicillin/Clavulanic acid - Abscess, Wound Infection
Phase 3CompletedBayer8132006-09-012014-11-07
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
piperacillin sodium, piperacillin-tazobactam, tazobactam sodium - Bone Marrow Suppression, Fever, Sweats, and Hot Flashes
Phase 3CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC8591997-11-012012-09-24
Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma
Piperacillin/Tazobactam (Tazocin) - Hematologic Neoplasms
Phase 3CompletedWyeth is now a wholly owned subsidiary of Pfizer2007-10-10

Conditions studied

Infections (3)  ·  Diabetic Foot (2)  ·  Abscess (1)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Dendritic Cell Sarcoma, Interdigitating (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Fever (1)  ·  Hematologic Neoplasms (1)  ·  Hodgkin Disease (1)  ·  Hot Flashes (1)  ·  Leukemia (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)

Sponsors

Merck Sharp & Dohme LLC (2)  ·  Assaf-Harofeh Medical Center (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Bayer (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Melinta Therapeutics, Inc. (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

France (3)  ·  Greece (3)  ·  Israel (3)  ·  United States (3)  ·  Belgium (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  Hungary (2)  ·  Italy (2)  ·  Poland (2)  ·  Romania (2)  ·  Slovakia (2)  ·  Spain (2)

Top investigators

Arie Soroksky, MD (1)  ·  Karen Fusaro (1)  ·  Keith Kaye (1)  ·  Michel P. Glauser, MD (1)

Results publications

PMID 21896561, PMID 23180507, PMID 26888908, PMID 29486041, PMID 31786695, PMID 32785589, PMID 34704389, PMID 37383243, PMID 41586496, PMID 42743113

NIH funding

2015 (1)